
Uppsala Reports editor
@UMCGlobalSafety
Henry Zakumumpa from Makerere University School of Public Health airs his research on HIV care and treatment strategies in Uganda and the need for more robust pharmacovigilance.
With the right care, people infected with HIV can lead long and healthy lives. But as with any life-long medical treatment, it is important to acknowledge and manage any side effects.
In the latest episode of Drug Safety Matters, Henry Zakumumpa from Makerere University School of Public Health tells podcast host Federica Santoro about the potential harms of new HIV therapies and the challenges faced by pharmacovigilance specialists in Uganda.
Subscribe by visiting the Drug Safety Matters website or listen in right here:
ISoP’s 2022 annual meeting was themed “A New Era of Pharmacovigilance: Challenges and Opportunities”. Independent consultant Mary Stapleton shares her observations of the event.
In focus / 15 November 2022
A patient’s perspective can lead to new insights that traditional research may overlook. Yet how may we best harness their perspective to improve patient outcomes?
In focus / 06 September 2023
A patient’s perspective is powerful in ensuring safe medical care. Yet how may we best harness their perspective to improve patient outcomes?
In focus / 26 June 2023